THE WAYNE-STATE-UNIVERSITY EXPERIENCE WITH ADJUVANT CHEMOTHERAPY OF HEAD AND NECK-CANCER

[31] KISH J, 1982, CANCER TREAT REP, V66, P471

[32] KISH J, 1984, P AM ASSOC CANC RES, V25, P173

[33] EVALUATION OF HIGH-DOSE CISPLATIN AND 5-FU INFUSION AS INITIAL THERAPY IN ADVANCED HEAD AND NECK-CANCER [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (05): : 553 - 557

[34] KRAMER S, 1985, HEAD NECK SURG, V3, P255

[35] KSIH JA, 1989, P AM SOC CLIN ONCOL, V8, P173

[36] OBRIEN PH, 1971, CANCER-AM CANCER SOC, V27, P304, DOI 10.1002/1097-0142(197102)27:2<304::AID-CNCR2820270209>3.0.CO

[37] 2-1

[38] PAPAC RJ, 1984, CANCER, V53, P342, DOI 10.1002/1097-0142(19840115)53:2<342::AID-CNCR2820530228>3.0.CO

[39] 2-9

[40] PROBERT JC, 1974, CANCER, V33, P127, DOI 10.1002/1097-0142(197401)33:1<127::AID-CNCR2820330119>3.0.CO

[31] KISH J, 1982, CANCER TREAT REP, V66, P471

[32] KISH J, 1984, P AM ASSOC CANC RES, V25, P173

[33] EVALUATION OF HIGH-DOSE CISPLATIN AND 5-FU INFUSION AS INITIAL THERAPY IN ADVANCED HEAD AND NECK-CANCER [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (05): : 553 - 557

[34] KRAMER S, 1985, HEAD NECK SURG, V3, P255

[35] KSIH JA, 1989, P AM SOC CLIN ONCOL, V8, P173

[36] OBRIEN PH, 1971, CANCER-AM CANCER SOC, V27, P304, DOI 10.1002/1097-0142(197102)27:2<304::AID-CNCR2820270209>3.0.CO

[37] 2-1

[38] PAPAC RJ, 1984, CANCER, V53, P342, DOI 10.1002/1097-0142(19840115)53:2<342::AID-CNCR2820530228>3.0.CO

[39] 2-9

[40] PROBERT JC, 1974, CANCER, V33, P127, DOI 10.1002/1097-0142(197401)33:1<127::AID-CNCR2820330119>3.0.CO